This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
See you next year! September 15-18, 2025
Hynes Convention CenterBoston, MA

Dan Zarraga
Head of GMU Drug Product · Biologics Drug Product Dev. & Manufacturing at Sanofi
Speaker

Profile

Dan Zarraga has been involved in biopharma drug product development and strategic innovation for more than 15 years and has held leadership roles in product development in several companies. He obtained his PhD in Chemical engineering at the Univ Notre Dame in polymer suspensions and went on to take an Industrial-Academe Postdoc at Abbott Labs and Georgia Tech on Microencapsulation. Inspired by his exposure to pharma development at Abbott, he went on to work for 3M Health care on vaccine adjuvant formulations, and their application to cancer vaccines. In 2008 he moved to San Francisco to work for Genentech on small protein and mAb formulation and process development and was also involved in a collaboration with BioNTech using novel mRNA-lipid nanoparticles (LNPs) for personalized cancer vaccines.

In 2018 he was hired by Sanofi Genzyme in greater Boston to expand their drug product development group and capabilities from enzymes to mAbs, LNPs, AAVs, and cell therapy modalities, and from lab to clinical scale. He is currently Senior Director of Biologics DP and Head of Genomic medicines DP development. Through his career, Dan has also helped facilitate the establishment of several industrial-academe collaborations and consortia such as NIIMBL, nSOFT, and BITC, and has enabled international collaborations within his industry work and outside.

Agenda Sessions

  • Considerations for Cryopreservation of Allogeneic NK-Cell Drug Product

    2:45pm